Enterogermina®, a consumer healthcare brand under Opella, has expanded its early-childhood probiotic offerings with the rollout of Enterogermina® Minies. Announced in Istanbul on September 10, 2026, the formulation addresses early-stage gut microbiota development through an evidence-based pediatric wellness approach.
Packaged in an 8 ml dropper liquid format, the product is administered at an intake of 6 drops once daily. It can be ingested directly or mixed into compatible foods, offering a neutral sensory profile free from added flavorings, gluten, and lactose.
Science-Based Formula with BB-12® Probiotics
Key technical and nutritional specifications include:
Active Probiotic Strain: Every 6 drops supply Bifidobacterium animalis subsp. lactis (BB-12®), a globally recognized probiotic strain supported by extensive clinical research.
Microbiota Support: Formulated to assist gut flora balance and overall digestive well-being in toddlers and young children.
Packaging and Dosage: Delivered in an 8 ml dropper format with a recommended dosage of 6 drops taken once per day.
Clean Formulation: Free from gluten, lactose, and added flavorings.
Executive Commentary from Feirouz Ellouze
Feirouz Ellouze, General Manager of Opella Africa, Middle East, and Turkey (AMET), stated:
“At Opella, we aim to put health in more people's hands through solutions that make a tangible difference in everyday life. For parents, ensuring that young children experience digestive comfort and grow happily is paramount. That need drove our development of Enterogermina® Minies Comfort. By supporting digestive health from an early stage, we strive to help children feel better and thrive peacefully, while assisting parents in enjoying restful nights and happier days. This philosophy lies at the core of our commitment to converting science into impactful health solutions for families.”
About Opella
Headquartered in France, Opella holds the third-largest product portfolio in the global vitamins, minerals, and supplements (VMS) sector. The B Corp-certified self-care manufacturer reaches over 500 million consumers through 100 brands—including Enterogermina and Pharmaton—backed by 11,000 employees, 13 manufacturing plants, and 4 dedicated innovation hubs.
